2014-02-11 13:28:25 UTC

Improving Celiac Disease Risk Prediction by Testing Additional Non-HLA Variants

Feb. 13, 2014

Publishing in Gut, Jihane Romanos and colleagues find that predicting risk with 57 additional non-HLA variants, in addition to HLA variants, improves the identification of potential celiac disease patients.

The majority of celiac disease patients are not being properly diagnosed and therefore remain untreated, leading to a greater risk of developing celiac-associated complications. The major genetic risk heterodimer, HLA-DQ2 and -DQ8, is already used clinically to help exclude disease. However, approximately 40 percent of the population carries these alleles and the majority never develop celiac disease. Reporting in Gut, Jihane Romanos and colleagues find that predicting risk with 57 additional non-HLA variants improves the identification of potential celiac disease patients. This demonstrates a possible role for combined HLA and non-HLA genetic testing in diagnostic work for celiac disease.

Gut 2014: 63: 415-422

More on Celiac Disease

The Lowdown on the Low-FODMAP Diet

Nov. 1, 2017

As the low-FODMAP diet grows in popularity, know the facts to help answer patient questions and provide guidance.

Spotlight on Fellow-Led Quality Improvement Projects

Oct. 3, 2017

These 19 projects presented at DDW® 2017 showcase the extensive work being done by fellows to improve the quality of care provided to GI patients.

Avoidance of Cow's Milk–Based Formula for At-Risk Infants Does Not Reduce Development of Celiac Disease: A Randomized Controlled Trial

Oct. 1, 2017

Increased cow's milk antibody titers before the appearance of anti-TG2A and celiac disease indicates that subjects with celiac disease might have increased intestinal permeability in early life.